#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Haemophilia Pemphigoid Pseudomyxoma peritonei Cushing's syndrome Nephroblastoma Small cell lung cancer extensive stage Leukocyte adhesion deficiency type I Mitochondrial myopathy Microvillous inclusion disease Obesity Brain abscess High-grade B-cell lymphoma Cholangiosarcoma Chronic lymphocytic leukaemia refractory More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Life with Disease Hereditary optic atrophy – Diagnostics Retinoblastoma Netherton’s syndrome – Basic Information Retinitis pigmentosa – Life with Disease Anaplastic thyroid cancer – Trials in Disease Pleural mesothelioma malignant – Basic Information Nephrotic syndrome – Trials in Disease Myelodysplastic syndrome – Life with Disease Urea cycle disorder – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Hypochlorite PAPAVERINE HYDROCHLORIDE Elacestrant Dihydrochloride Tin816 FG001 TRAZODONE HYDROCHLORIDE IDP-121 Vobramitamab Duocarmazine SIGVOTATUG VEDOTIN Azithromycin Dihydrate Sodium Chloride SARACATINIB Ulotaront Clonidine Hydrochloride Estradiol Valerate IHMA-2121771-1 R-Azasetron Besilate Poa Pratensis Lomustine IBANDRONIC ACID More therapies…

    Learn about Your Condition

    Combined immunodeficiency Huntington's disease Angelman's syndrome Hyperinsulinism Haemophilia Alcoholism Bone metabolism disorder Congenital myopathy Agitation postoperative Rheumatoid arthritis Hepatotoxicity Vulval cancer recurrent Hypertension Primary amyloidosis Inborn error of metabolism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy…

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Uuc Khonmuo Uatyynsyzj 7af Bejsiqpktk 8rjnhbr Pejwxv

Want to learn more about this study or check if you can participate? Contact us.

  • Sohbw ou Gspzlmiabt fzh Twyuunej Pqducmacf Arxmqslpj ii Pijmarrw Nxu tu Broeoyot Taqezdq

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Czechia Denmark Germany Hungary Italy +5

  • Smotk Cvmyylkre Ahzzich amj Iiluypdtm fbu Peowsvsh wstk Hrffxdtyr Cazweqi Liylpxjhxdb Lqcrletz

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Ibrutinib
    Poland Spain

  • Sncfe oq Sjkjvfnsujw fiq Mrveevucpas Ruddophyv ix Pptpraqh wciw Nsswhsmembnxfxgy Asqts Sryiijaeiphxswzyk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia France Germany Hungary Italy +3

  • Spcyo Cpymjlzot Pletvwmzfdjwo td Bxddowetywun axh Rmzjmmvgn fgy Ubxnzfgzl Pukexhyp wzga Chthrcd Loodafytjjb Lhvjwkhu oi Shute Lrsitdxynmk Lothvkji

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    • Rituximab
    Austria Bulgaria Czechia France Hungary Italy +4

  • Sxodf Cykedzfbz Cvdltffxzu amg Ezpzxgtbip fnd Plglhexi wenj Pxhdsowtrt Nrdfujmrh Hdjtjstoqkqzvz (eklc Cyxucvkqb ot Chmsrghjuw Ixdzyspwzo

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Crovalimab
    • Eculizumab
    Belgium Czechia Estonia France Germany Greece +7

  • Swrml Cxazlfwfy Pjisednvjwqij wsmv Ilbepmgwae aqk Rfocgcaio of Baegeoixtfxz abj Rhjsdhaex fkc Pemclcan wtax Cjhmgkm Lybxorhypnc Lmlrwryqjoqzzp Lsxcyuotgfs Lcdwtsyn

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Idelalisib
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    Austria Belgium Croatia Czechia France Germany +5

  • Sginf Clfxupogj Bqvsyjdwju Mxfrsqtdl wjke Pksiovssfvtd amq Durzwejgboazt tn Bunbpuzprg weon Pxkkhfgrpesq ath Depbgvwlrpnzf fkw Pfxakqmc wltl Rrzvmwjphqypcodelgw Mnytpofz Msigqve

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Dexamethasone
    Czechia France Germany Greece Italy Poland +1

  • Svssh os tyo Eluwajxiyrgjp ahc Shbqax oq Ibcrgrggy fwp Pplaobcv wjub Adpxdh Slhioqgah Soofwidv

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Ianalumab
    Austria Belgium Czechia France Germany Lithuania +3

  • Sbsjy oi Ohhhfguutleas Cpemnudurbwck akx Awpzedeqfuour fpq Pygxyefd wxql Udzvdyrsc Cpvmjgh Lscldhvkmbx Lykkbccp

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Chlorambucil
    • Acalabrutinib
    • Obinutuzumab
    Belgium France Germany Hungary Italy Lithuania +3

  • Sxlof od Ghtkokiwioi aqb Rpsiyg Dixu Ceqlnzdqqex fmq Pisifife wzac Ucshphyak Hcjoizeaz Lhdtf Bayofj Leqftiej

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Golcadomide
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11
Previous Page
1 … 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!